Donate
Search This Site
Click here to see the full Winter 2022 issue of Pulse.
$300 million investment will accelerate UVA’s development of revolutionary cellular and gene therapies, nanotechnology, and targeted drug delivery.
Investing in Hope
A major gift from longtime School of Nursing benefactors takes aim at the nation’s nursing shortage.
Give to UVA
UVA’s pediatric predictive analytics technology is improving patient outcomes.
Andy Levinsky